News and Analysis

Beckley Psytech fetches $80m Series B

Beckley Psytech, a UK-based developer of psychedelic medicines, has raised $80 million in Series B financing.

-

Beckley Psytech, a UK-based developer of psychedelic medicines, has raised $80 million in Series B financing. Integrated led the round.

Source: Press Release